These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19018038)

  • 1. Apoprotein E as a lipid transport and signaling protein in the blood, liver, and artery wall.
    Getz GS; Reardon CA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S156-61. PubMed ID: 19018038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Domains of apolipoprotein E contributing to triglyceride and cholesterol homeostasis in vivo. Carboxyl-terminal region 203-299 promotes hepatic very low density lipoprotein-triglyceride secretion.
    Kypreos KE; van Dijk KW; van Der Zee A; Havekes LM; Zannis VI
    J Biol Chem; 2001 Jun; 276(23):19778-86. PubMed ID: 11279066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
    Barbagallo CM; Rizzo M; Noto D; Frasheri A; Pernice V; Rubino A; Pieri D; Pinto V; Cefalù AB; Giordano C; Notarbartolo A; Averna MR
    Metabolism; 2006 May; 55(5):662-8. PubMed ID: 16631444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
    Craig WY; Nutik R; Cooper AD
    J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSRC1 overexpression attenuates atherosclerosis progression in apoE
    Guo K; Hu L; Xi D; Zhao J; Liu J; Luo T; Ma Y; Lai W; Guo Z
    J Mol Cell Cardiol; 2018 Mar; 116():69-80. PubMed ID: 29378206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake of apolipoprotein E-rich and apolipoprotein E-poor subfractions of high-density lipoprotein by liver membranes and HepG2 cells.
    Fragoso YD; Skinner ER
    Biochem J; 1995 Oct; 311 ( Pt 2)(Pt 2):611-5. PubMed ID: 7487903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoprotein E and Reverse Cholesterol Transport.
    Getz GS; Reardon CA
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased atherosclerosis in P2Y13/apolipoprotein E double-knockout mice: contribution of P2Y13 to reverse cholesterol transport.
    Lichtenstein L; Serhan N; Espinosa-Delgado S; Fabre A; Annema W; Tietge UJ; Robaye B; Boeynaems JM; Laffargue M; Perret B; Martinez LO
    Cardiovasc Res; 2015 May; 106(2):314-23. PubMed ID: 25770145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial lipase modulates HDL but has no effect on atherosclerosis development in apoE-/- and LDLR-/- mice.
    Ko KW; Paul A; Ma K; Li L; Chan L
    J Lipid Res; 2005 Dec; 46(12):2586-94. PubMed ID: 16199802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic CGI-58 expression in macrophages alleviates the atherosclerotic lesion development in ApoE knockout mice.
    Xie P; Zeng X; Xiao J; Sun B; Yang D
    Biochim Biophys Acta; 2014 Dec; 1841(12):1683-90. PubMed ID: 25178844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective suppression of adipose tissue apoE expression impacts systemic metabolic phenotype and adipose tissue inflammation.
    Huang ZH; Reardon CA; Getz GS; Maeda N; Mazzone T
    J Lipid Res; 2015 Feb; 56(2):215-26. PubMed ID: 25421060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation.
    Tran-Lundmark K; Tran PK; Paulsson-Berne G; Fridén V; Soininen R; Tryggvason K; Wight TN; Kinsella MG; Borén J; Hedin U
    Circ Res; 2008 Jul; 103(1):43-52. PubMed ID: 18596265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.
    Westerterp M; Van Eck M; de Haan W; Offerman EH; Van Berkel TJ; Havekes LM; Rensen PC
    Atherosclerosis; 2007 Nov; 195(1):e9-16. PubMed ID: 17320883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice.
    White EJ; Gyulay G; Lhoták Š; Szewczyk MM; Chong T; Fuller MT; Dadoo O; Fox-Robichaud AE; Austin RC; Trigatti BL; Igdoura SA
    J Biol Chem; 2018 Sep; 293(38):14689-14706. PubMed ID: 30097518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW; Ragland JB; Sabesin SM
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular catabolism of lipid poor apolipoprotein E via cell surface LDL receptor-related protein.
    Narita M; Holtzman DM; Fagan AM; LaDu MJ; Yu L; Han X; Gross RW; Bu G; Schwartz AL
    J Biochem; 2002 Nov; 132(5):743-9. PubMed ID: 12417024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminal 1-185 domain of apoE promotes the clearance of lipoprotein remnants in vivo. The carboxy-terminal domain is required for induction of hyperlipidemia in normal and apoE-deficient mice.
    Kypreos KE; Morani P; van Dijk KW; Havekes LM; Zannis VI
    Biochemistry; 2001 May; 40(20):6027-35. PubMed ID: 11352738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.